Advertisement
Advertisement
LAB
Standard BioTools Inc. Common Stock
1.02
USDSponsored
+0.02
+2.00%
May 08, 16:00 UTC -4
Closed
After-Market
1.01
-0.01
-0.49%
LAB Earnings Reports
Positive Surprise Ratio
LAB beat 17 of 36 last estimates.
47%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$21.09M
/-$0.04
Implied change from Q1 26 (Revenue/ EPS)
-0.31%
/+100.00%
Implied change from Q2 25 (Revenue/ EPS)
-49.75%
/-55.56%
Standard BioTools Inc. Common Stock earnings per share and revenue
On May 05, 2026, LAB reported earnings of -0.02 USD per share (EPS) for Q1 26, beating the estimate of -0.06 USD, resulting in a 67.00% surprise. Revenue reached 21.15 million, compared to an expected 18.09 million, with a 16.89% difference. The market reacted with a -1.07% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 21.09 million USD, implying an increase of 100.00% EPS, and decrease of -0.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
$0.83
Actual
$0.89
Surprise
+6.65%
Clover Health Investments, Corp
Report Date
May 06, 2026 For Q1 26
Estimate
$0.03
Actual
$0.07
Surprise
+128.76%
Claritev Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
-$4.08
Actual
-$4.41
Surprise
-7.90%
Evolent Health, Inc Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.02
Surprise
+61.39%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.02
Surprise
+1.96%
CareCloud, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.05
Surprise
+835.29%
American Well Corporation
Report Date
May 05, 2026 For Q1 26
Estimate
-$1.18
Actual
-$0.78
Surprise
+33.98%
Outset Medical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-2.00%
10x Genomics, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.10
Surprise
+66.04%
Privia Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.07
Actual
$0.02
Surprise
-73.72%
FAQ
What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Standard BioTools Inc. Common Stock reported EPS of -$0.02, beating estimates by 67%, and revenue of $21.15M, 16.89% above expectations.
How did the market react to Standard BioTools Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -1.07%, changed from $0.98 before the earnings release to $0.97 the day after.
When is Standard BioTools Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?
Based on 4
analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.04 and revenue of $21.09M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement